On Mar 10, 2022 Scenic Biotech closed a Series A round and raised €28,000,000 from BioGeneration Ventures, BioMedPartners, EIR Ventures, INKEF Capital, Oxford Science Enterprises, Vesalius Biocapital Partners, featuring lead investors BioMedPartners, EIR Ventures, Vesalius Biocapital Partners.

About the company: Scenic Biotech is located at The Netherlands, Europe.
“We are pioneers in the discovery of genetic modifiers to enable the development of transformative therapeutics.”

Company website: http://www.scenicbiotech.com